Mantovani, L.G. et al. 2022. Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy. Farmeconomia. Health economics and therapeutic pathways. 23, 1 (Feb. 2022). DOI:https://doi.org/10.7175/fe.v23i1.1510.